Aurinia Pharmaceuticals Inc. (AUPH)
NASDAQ: AUPH · Real-Time Price · USD
16.12
-0.25 (-1.53%)
At close: Nov 28, 2025, 1:00 PM EST
16.24
+0.12 (0.74%)
After-hours: Nov 28, 2025, 4:24 PM EST

Aurinia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202015 - 2019
Period Ending
Nov '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
2,1251,2861,2916142,9661,750
Upgrade
Market Cap Growth
74.83%-0.41%110.30%-79.30%69.42%-20.79%
Upgrade
Enterprise Value
1,8481,0251,0472462,6881,367
Upgrade
Last Close Price
16.378.988.994.3222.8713.83
Upgrade
PE Ratio
29.30223.53----
Upgrade
Forward PE
19.9024.06----
Upgrade
PS Ratio
8.435.477.364.5865.0334.93
Upgrade
PB Ratio
5.903.413.421.516.194.29
Upgrade
P/TBV Ratio
5.863.453.461.546.304.39
Upgrade
P/FCF Ratio
17.7329.15----
Upgrade
P/OCF Ratio
17.6628.97----
Upgrade
EV/Sales Ratio
6.954.365.971.8458.9427.27
Upgrade
EV/EBITDA Ratio
18.3832.08----
Upgrade
EV/EBIT Ratio
22.7981.91----
Upgrade
EV/FCF Ratio
15.4523.25----
Upgrade
Debt / Equity Ratio
0.210.210.260.020.020.02
Upgrade
Debt / EBITDA Ratio
0.772.42----
Upgrade
Debt / FCF Ratio
0.651.80----
Upgrade
Asset Turnover
0.490.430.350.260.090.13
Upgrade
Inventory Turnover
1.261.241.982.303.14-
Upgrade
Quick Ratio
5.024.054.868.7611.8412.45
Upgrade
Current Ratio
5.764.575.509.6012.6313.11
Upgrade
Return on Equity (ROE)
20.65%1.52%-19.92%-24.46%-40.81%-29.07%
Upgrade
Return on Assets (ROA)
9.41%1.42%-10.53%-13.74%-22.43%-16.54%
Upgrade
Return on Capital (ROIC)
11.02%1.68%-12.06%-15.46%-24.99%-18.24%
Upgrade
Return on Capital Employed (ROCE)
18.00%2.80%-18.20%-26.20%-36.00%-24.20%
Upgrade
Earnings Yield
3.67%0.45%-6.04%-17.62%-6.10%-5.87%
Upgrade
FCF Yield
5.64%3.43%-2.65%-13.00%-5.33%-4.32%
Upgrade
Buyback Yield / Dilution
1.24%-2.07%-0.93%-9.70%-9.20%-27.36%
Upgrade
Updated Nov 4, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q